fulvestrant has been researched along with Cardiac Remodeling, Ventricular in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradley, JM; El Hajj, EC; El Hajj, MC; Gardner, JD; Ninh, VK | 1 |
Ackerman, A; Aronovitz, MJ; Baker, C; Donaldson, C; Eder, S; Hall-Porter, M; Karas, RH; Molkentin, JD; Patten, RD; Wang, F; Weiss, AD | 1 |
Danalache, B; Gangal, M; Gutkowska, J; Jankowski, M; Wang, D | 1 |
Albrecht, M; Brown, JA; Brown, MB; Dieudonne, D; Fisher, AJ; Justice, MJ; Lahm, T; Patel, NG; Petrache, I; Presson, RG; Reddy, JG; Selej, M; Trulock, KM; Van Demark, M | 1 |
4 other study(ies) available for fulvestrant and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats.
Topics: Animals; Aorta; Arteriovenous Shunt, Surgical; Collagen; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Heart; Hypertrophy, Left Ventricular; Myocardium; Rats; Rats, Sprague-Dawley; Stroke Volume; Vena Cava, Inferior; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2017 |
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Topics: Animals; Animals, Newborn; Calcineurin; Cell Size; Cells, Cultured; Disease Models, Animal; Drug Implants; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardial Contraction; Myocardium; Myocytes, Cardiac; NFATC Transcription Factors; Ovariectomy; Phenylephrine; Proteasome Endopeptidase Complex; Receptors, Estrogen; Signal Transduction; Time Factors; Ubiquitin; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fibrosis; Fulvestrant; Genistein; Hypertension; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; Ovariectomy; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Oxytocin; RNA, Messenger; Vasotocin; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |
17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.
Topics: Airway Remodeling; Animals; Blood Pressure; Cardiac Output; Cyclin-Dependent Kinase Inhibitor p27; Estradiol; Estrogen Antagonists; Fulvestrant; Hypertension, Pulmonary; Hypoxia; Lung; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Ventricular Remodeling | 2012 |